Beta Bionics, Inc. Common Stock (BBNX) is a publicly traded Healthcare sector company. As of July 28, 2026, BBNX trades at $15.82 with a market cap of $706.30M and a P/E ratio of -32.13. BBNX moved -1.31% today. Year to date, BBNX is -47.52%; over the trailing twelve months it is +7.75%. Its 52-week range spans $8.80 to $32.71. Analyst consensus is strong buy with an average price target of $18.80. Rallies surfaces BBNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover BBNX: 0 strong buy, 4 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $18.80.
| Metric | Value |
|---|---|
| Price | $15.82 |
| Market Cap | $706.30M |
| P/E Ratio | -32.13 |
| EPS | $-0.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.71 |
| 52-Week Low | $8.80 |
| Volume | 145.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $27.63M |
| Net Income | $-21.89M |
| Gross Margin | 59.50% |
5 analysts cover BBNX: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.80.